Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 3
1984 2
1985 2
1987 1
1989 1
1991 3
1992 3
1994 1
1996 2
1998 2
1999 4
2000 6
2002 2
2003 1
2005 1
2006 3
2007 2
2008 2
2010 4
2011 4
2012 2
2013 8
2014 8
2015 10
2016 8
2017 10
2018 9
2019 10
2020 10
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetics in breast and prostate cancer.
Wu Y, Sarkissyan M, Vadgama JV. Wu Y, et al. Among authors: vadgama jv. Methods Mol Biol. 2015;1238:425-66. doi: 10.1007/978-1-4939-1804-1_23. Methods Mol Biol. 2015. PMID: 25421674 Free PMC article. Review.
CCL2/CCR2 signaling in cancer pathogenesis.
Hao Q, Vadgama JV, Wang P. Hao Q, et al. Among authors: vadgama jv. Cell Commun Signal. 2020 May 29;18(1):82. doi: 10.1186/s12964-020-00589-8. Cell Commun Signal. 2020. PMID: 32471499 Free PMC article. Review.
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers.
Keung MYT, Wu Y, Vadgama JV. Keung MYT, et al. Among authors: vadgama jv. J Clin Med. 2019 Mar 30;8(4):435. doi: 10.3390/jcm8040435. J Clin Med. 2019. PMID: 30934991 Free PMC article. Review.
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.
Keung MY, Wu Y, Badar F, Vadgama JV. Keung MY, et al. Among authors: vadgama jv. J Clin Med. 2020 Mar 30;9(4):940. doi: 10.3390/jcm9040940. J Clin Med. 2020. PMID: 32235451 Free PMC article.
The role of PPM1D in cancer and advances in studies of its inhibitors.
Deng W, Li J, Dorrah K, Jimenez-Tapia D, Arriaga B, Hao Q, Cao W, Gao Z, Vadgama J, Wu Y. Deng W, et al. Among authors: vadgama j. Biomed Pharmacother. 2020 May;125:109956. doi: 10.1016/j.biopha.2020.109956. Epub 2020 Jan 29. Biomed Pharmacother. 2020. PMID: 32006900 Free article.
Celecoxib in breast cancer prevention and therapy.
Li J, Hao Q, Cao W, Vadgama JV, Wu Y. Li J, et al. Among authors: vadgama jv. Cancer Manag Res. 2018 Oct 26;10:4653-4667. doi: 10.2147/CMAR.S178567. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464589 Free PMC article. Review.
Epithelial-Mesenchymal Transition and Breast Cancer.
Wu Y, Sarkissyan M, Vadgama JV. Wu Y, et al. Among authors: vadgama jv. J Clin Med. 2016 Jan 26;5(2):13. doi: 10.3390/jcm5020013. J Clin Med. 2016. PMID: 26821054 Free PMC article. Review.
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
Cao W, Li J, Hao Q, Vadgama JV, Wu Y. Cao W, et al. Among authors: vadgama jv. Breast Cancer Res. 2019 Feb 21;21(1):29. doi: 10.1186/s13058-019-1107-2. Breast Cancer Res. 2019. PMID: 30791936 Free PMC article. Review.
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
Dillard C, Kiyohara M, Mah V, McDermott SP, Bazzoun D, Tsui J, Chan AM, Haddad G, Pellegrini M, Chang YL, Elshimali Y, Wu Y, Vadgama JV, Kim SR, Goodglick L, Law SM, Patel DD, Dhawan P, O'Brien NA, Gordon LK, Braun J, Lazar G, Wicha MS, Wadehra M. Dillard C, et al. Among authors: vadgama jv. Mol Cancer Ther. 2020 Aug;19(8):1682-1695. doi: 10.1158/1535-7163.MCT-19-0850. Epub 2020 May 25. Mol Cancer Ther. 2020. PMID: 32451329
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers.
Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Wu Y, et al. Among authors: vadgama jv. Cancers (Basel). 2020 Jul 16;12(7):1918. doi: 10.3390/cancers12071918. Cancers (Basel). 2020. PMID: 32708561 Free PMC article.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page